Actinomyces Spp
| Morphology | Gram positive rods, have filaments that are non-acid-fast and non-motile, most species
                                             are facultative anaerobes. | 
|---|---|
| Disease | Actinomycosis, gastrointestinal infections, gingivitis | 
| Zoonosis | None. | 
| Host Range | Humans and animals. | 
|---|---|
| Modes of Transmission | Ingestion, exposure to mucous membranes, exposure to open wounds. | 
| Signs and Symptoms | Abscess in area of exposure, redness and swelling in area of exposure, stomach pain. | 
| Infectious Dose | Unknown. | 
| Incubation Period | Mucous membranes: days to months; colonization of other areas may be days to years.  | 
| Prophylaxis | None. | 
|---|---|
| Vaccines | None. | 
| Treatment | Penicillin is usually effective, but amoxicillin, erythromycin, clindamycin, doxycycline,
                                                   and tetracycline are alternative antimicrobial choices. Tetracyclines are not recommended
                                                   for pregnant women or children younger than 8 years of age. Surgical drainage often
                                                   is a necessary adjunct to medical management and may allow for a shorter duration
                                                   of antimicrobial treatment. | 
| Surveillance | Monitor for symptoms. | 
| MSU Requirements | Report any exposure. | 
| Laboratory Acquired Infections (LAIs) | Cases have been reported. | 
|---|---|
| Sources | Samples from oral cavity (dental plaque, saliva, mucosal surfaces), blood, tissue
                                                      biopsy specimens, aspirates. Cultures, frozen stocks, other samples described in IBC
                                                      protocol. | 
| Canadian PSDS | |
|---|---|
| BMBL | |
| NIH Guidelines | 
| Risk Group 2 | Agents that are associated with human disease which is rarely serious and for which preventive or therapeutic interventions are often available. | 
|---|---|
| BSL2 | For all procedures involving suspected or known infectious specimen or cultures. | 
| ABSL2 | For all procedures utilizing infected animals. | 
| Small | Notify others working in the lab. Remove PPE and don new PPE. Cover area of the spill
                                                                  with absorbent material and add fresh 1:10 bleach:water. Allow 20 munutes (or as directed)
                                                                  of contact time. After 20 minutes, cleanup and dispose of materials. | 
|---|---|
| Large | 
 | 
| Mucous membrane  | Flush eyes, mouth, or nose for 5 minutes at eyewash station. | 
|---|---|
| Other Exposures  | Wash area with soap and water for 5 minutes.  | 
| Reporting | Immediately report incident to supervisor, complete a First Report of Injury form, and submit to Safety and Risk Management. | 
| Medical Follow-up  | During business hours: Bridger Occupational Health 3406 Laramie Drive. Weekdays 8am -6pm.  Weekends 9am-5pm After business hours: Bozeman Deaconess Hospital Emergency Room 915 Highland Blvd Bozeman, MT | 
| Disinfection | Susceptible to 1:10 bleach:water, 70% ethanol, 2% glutaraldehyde and peracetic acid
                                                               (0.001%-0.2%) | 
|---|---|
| Inactivation | Inactivated by moist heat (60 minutes at 121oC) and dry heat (1 hour at 160-170oC) | 
| Survival Outside Host | Survives in the environment for long periods of time. | 
| Minimum PPE Requirements | Lab coat, disposable gloves, safety glasses, closed toed shoes, long pants | 
|---|---|
| Additional Precautions | Additioanl PPE may be required depending on lab specific SOPs and IBC Protocol. | 
